Skip to main content
A-LevelBiologyGenetic technology9700/43 · May/June 2023 · Q410 Marks

One cause of the genetic disease severe combined immunodeficiency (SCID) is a mutation in the ADA gene. This mutation results in a deficiency of the enzyme adenosine deaminase (ADA). Although ADA is found throughout the body, it is especially active in lymphocytes. The absence of functional ADA causes the build-up of toxic metabolites that kill lymphocytes and damage organs. Babies are often diagnosed with SCID by six months old. Treatment can greatly improve the life expectancy of children with SCID. Some treatment options are available. • : Enzyme replacement therapy with recombinant human ADA made by genetically modified (GM) Escherichia coli. Weekly intra-muscular injections are given. Bone marrow transplant if a well-matched donor, such as a close relative, can be found. Gene therapy.

  1. (a)Suggest and explain why it may be more appropriate to use enzyme replacement therapy to treat SCID instead of a bone marrow transplant.[3]
  2. (b)Outline the procedure used for gene therapy treatment of a person with SCID.[4]
  3. (c)Suggest the social and ethical implications of gene therapy for SCID that need to be considered before treatment is carried out.[3]

Mark scheme

Marking points from the official mark scheme (May/June 2023). The mark or mark type is shown in brackets.

  1. any three from:
  2. [1] donor not needed ;
  3. [1] immediate effect ;
  4. [1] idea that easy to administer treatment ;
  5. [1] no immune response / no rejection ;
  6. [1] less invasive ;
  7. [1] AVP; e.g. lower risk to health / cheaper/quicker
  8. any four from:
  9. [1] given a drug to increase number of stem cells (in bone marrow) ;
  10. [1] ref. to virus / vector, containing, normal / healthy, allele ;
  11. [1] remove, bone marrow / stem cells ;
  12. [1] mix stem cells with, viral / vector (to allow transfer of normal allele) ;
  13. [1] radiotherapy / drug, to make space in bone marrow / to kill stem cells (in bone marrow) ;
  14. [1] (transduced stem) cells, infused / injected, into blood ;
  15. [1] (lymphocytes) produce functioning ADA ;
  16. [1] AVP; e.g. (gamma) retrovirus / adeno-associated virus e.g. tissue from bone marrow, purified / sorted, to obtain stem cells e.g. cells are grown in culture to check the ADA gene is active
  17. any three from:
  18. [1] expensive ;
  19. [1] cure / long term treatment / no longer chronically ill / better quality of life ;
  20. [1] no need for regular, injections / treatments or only a single treatment ;
  21. [1] cultural/religious, objections ;
  22. [1] no donor needed ;
  23. [1] ref. more money available to health system in the long term;
  24. [1] may cause cancer ;
  25. [1] stressful ;

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Genetic technology, A-Level Biology (syllabus 9700). Structured question, 10 marks.
Source
A-Level Biology, May/June 2023 Paper 4 Variant 3, question 4.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep